Pegasys and Pollakiuria - a phase IV clinical study of FDA data

Summary:

Pollakiuria is reported as a side effect among people who take Pegasys (peginterferon alfa 2a), especially for people who are male, 50-59 old, have been taking the drug for 1 - 6 months also take Ribavirin, and have High blood pressure.

The phase IV clinical study analyzes which people have Pollakiuria when taking Pegasys. It is created by eHealthMe based on reports of 57,338 people who have side effects when taking Pegasys from the FDA, and is updated regularly.

What is Pegasys?

Pegasys has active ingredients of peginterferon alfa 2a. It is often used in hepatitis c. eHealthMe is studying from 57,446 Pegasys users. Check the latest studies of Pegasys.

What is Pollakiuria?

Pollakiuria (abnormally frequent passage of relatively small quantities or urine) is found to be associated with 1,749 drugs and 1,692 conditions by eHealthMe. Check the latest studies of Pollakiuria.

On Jul, 05, 2026

57,338 people reported to have side effects when taking Pegasys.
Among them, 216 people (0.38%) have Pollakiuria.

Among these 216 people:

* Approximation only. Some reports may have incomplete information.

Do you take Pegasys and have Pollakiuria?

- Check whether Pollakiuria is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pegasys:

Pegasys (57,446 reports)

Pollakiuria treatments and more:

Pollakiuria (53,752 reports)

How severe was Pollakiuria and when was it recovered:

Pollakiuria in Pegasys

Expand to all the drugs that have ingredients of peginterferon alfa 2a:

Pollakiuria and drugs with ingredients of peginterferon alfa 2a

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pegasys:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pollakiuria:

Pollakiuria (1,749 drugs)

Browse all the conditions that are associated with Pollakiuria:

Pollakiuria (1,692 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on peginterferon alfa 2a (the active ingredients of Pegasys) and Pegasys (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.